Anavi Khosla - Business Management Internal Assessment
Anavi Khosla - Business Management Internal Assessment
Anavi Khosla - Business Management Internal Assessment
Internal Assessment
1
Contents Page Numbers
Introduction 3
Qualitative Analysis 4
SWOT Analysis 4
Ansoff Matrix 7
Quantitative Analysis 8
Profitability Ratios 8
Conclusion 11
2
Research Question: To what extent did Bayer’s acquisition of Monsanto
Introduction:
Bayer, a large German life science company that is famous for producing Aspirin,
operates under the name Bayer, focuses mostly on agricultural productivity, and
seeds and genomics, and is known for producing genetically modified seeds and the
companies, and they settled on the sale of Monsanto at 128 U.S. dollars per share
with the total amounting to 63 billion U.S. dollars taking into account Monsanto’s
debt, and 66 billion dollars without accounting for the debt 2. After getting all the
required US and EU regulatory approvals, the deal moved forward. Bayer fully
acquired Monsanto on June 7, 2018. This essay will analyze how Bayer’s acquisition
of Monsanto impacted their profitability and share prices, and whether it was
effective or not. I will determine this through the use of different tools such as SWOT
Qualitative Analysis:
1
Allgood, Evan. “A Timeline of Monsanto's Roundup Controversy & Lawsuits.” ClassAction.com, 24
Aug. 2018, www.classaction.com/news/timeline-monsanto-roundup-controversy/
2
Supporting Document 5
3
SWOT Analysis of the Merger:
Strengths:
agrochemical products and combining their expertise can lead to the audience
- Both companies have projects in overlapping fields and by merging, costs can
be cut, and money can be saved by merging similar projects into one 3.
- The World Health Organization and the USA Food and Drug Administration
(FDA) have both vouched for the safety of biotech crops, which decreases
- The merger would allow Bayer to save $1.5 billion a year in costs 3.
does not have a good ethical reputation 4. Merging with Bayer and getting rid
- Merging the two companies will increase competition between the employees
of the companies. This can help in increasing productivity, changing the work
3
Supporting Document 1
4
Dewey, Caitlin. “Why 'Monsanto' Is No More.” The Washington Post, WP Company, 27 Apr. 2019,
www.washingtonpost.com/news/wonk/wp/2018/06/04/why-monsanto-is-no-more/.
4
- Bayer’s patents on its two top selling drugs would run out in 2023, and the
Weaknesses:
- Monsanto has many legal liabilities and cases against them due to the
negative effects of the products they sell, and Bayer must assume these legal
and payouts can be expensive and can also cause damage to the company’s
reputation1.
- By merging the two companies, there is less competition and less companies
reputation with consumers4 and this can impact Bayer’s reputation and image
- Merging the two companies will increase the number of obstacles employees
must jump through to pitch their ideas, and this can discourage invention and
creativity5.
- Bayer’s shareholders were not convinced about the merger 6 and this can
cause shareholders to lose confidence in the company, sell stock and cause a
5
Bender, Ruth. “How Bayer-Monsanto Became One of the Worst Corporate Deals-in 12 Charts.” The
Wall Street Journal, Dow Jones & Company, 28 Aug. 2019, www.wsj.com/articles/how-bayer-
monsanto-became-one-of-the-worst-corporate-dealsin-12-charts-11567001577#refreshed
6
Stam, Claire. “Bayer Nearing Monsanto Deal amid Stakeholders Concerns.” Www.euractiv.com,
EURACTIV.com, 31 May 2018, www.euractiv.com/section/agriculture-food/news/bayer-nearing-
monsanto-deal-amid-stakeholders-concerns/.
5
- Bayer could lose investors as many investors invested in the company’s
agricultural industry, and investors could worry that Bayer’s focus would shift,
Opportunities:
convert them into strengths which can lead to geographic expansion, increase
Threats:
- The US FDA has condemned and deemed many of the chemicals used in
Monsanto’s array of product unsafe and harmful to humans, which can lead to
genetically modified crops, and this can cause a decrease in sales and
profits3.
- Competition from companies like Dow Chemical Company and Syngenta can
6
Ansoff Matrix:
The Ansoff Matrix is a tool used by firms to analyze and plan their strategy for
growth7. The table is divided into four parts, each talking about different product and
market mixes along with their benefits and risks. Bayer’s acquisition of Monsanto can
also be studied through the matrix. Monsanto was a top competitor in the GMO
market while Bayer produced herbicides. Herbicides are made to kill weeds, which a
plant can’t be genetically altered to resist, however a plant can be altered to resist
herbicides, causing a substantial increase in herbicide production and use 8. This can
market with existing products. This strategy often involves catering to a different
customer segment. Bayer was able to enter the GMO market, a new market that
they did not previously work in, with their existing herbicide products. They targeted
a new customer segment, namely those who grow genetically modified organisms
through this strategy. This would mean Bayer’s customers and revenue on
7
“Ansoff Matrix - Overview, Strategies and Practical Examples.” Corporate Finance Institute, 6 July
2020, corporatefinanceinstitute.com/resources/knowledge/strategy/ansoff-matrix/.
8
Supporting Document 4
7
Quantitative Analysis:
Profitability Ratios:
exceeds the cost of goods sold9. For every dollar earned, the gross profit margin is
how much of that dollar is gross profit. Gross profit can also be calculated as
9
Carlson, Rosemary. “What Is Gross Profit Margin?” The Balance Small Business, 23 Dec. 2020,
www.thebalancesmb.com/what-is-the-gross-profit-margin-393201
8
Bayer’s gross profit margin steadily increased till 2018 when they acquired
Monsanto. Post the merger, their GPM dropped steadily. This could be attributed to
lower sales and revenue, which could be a direct result of a higher cost of goods,
their patents expiring on popular products, or the negative reputation that Monsanto
held.10 It could also be due to the legal fees and settlements due to the pending
lawsuits against Monsanto that Bayer had legal responsibility due to the merger. 11 A
lower GPM means there would be less money to cover operating or other costs.
Net profit margin is the ratio of net profit to revenue and shows how much of each
dollar collected by a company as revenue translates to profit 12. This can be a better
10
Supporting Document 4
11
Supporting Document 2
12
Maverick, J.B. “The Difference Between Gross Profit Margin and Net Profit Margin.” Investopedia,
Investopedia, 19 May 2021, www.investopedia.com/ask/answers/021215/what-difference-between-
gross-profit-margin-and-net-profit-margin.asp
9
NPM: [(Net income) x 100] / Revenue
Bayer’s net profit margin rose from 2017 to 2018, after which it began to decline.
This could be due to higher operating expenses due to the merging of Monsanto and
all their products and projects, which the parent company now had to fund. Since
10
Monsanto was still running their projects while not bringing in much revenue due to
the pending lawsuits and toxicity of their products, expenses increased while
revenue and net income did not.13 A low NPM could show that the business is not
making a profit on its products and that it has poor pricing strategies, and this
impacts Bayer as profits are reinvested into the business and could be used for new
Conclusion:
Based on the SWOT analysis conducted, the merger threats and the liabilities it
holds strongly outweigh the benefits. Bayer has suffered greatly by having to take on
legal responsibilities for lawsuits, increased expenses, drop in revenue due to certain
The gross profit margin and net profit margin also fell post the merger, which is often
expected as the companies find a way to merge and work together. However, the
GPM and NPM did not recover and continued to steadily decline due to possibilities
such as increased expenses, less revenue, ethical concerns, and brand identity
that the merger was not effective and caused more harm to Bayer.
Bibliography
13
Supporting Document 2
11
Supporting Document 1: Balasubramanian, Anupama. “Bayer-Monsanto Acquisition: Who
acquisition-who-wins/
12
13
Supporting Document 2: “Bayer Gross Margin 2006-2021: BAYRY.” Macrotrends,
www.macrotrends.net/stocks/charts/BAYRY/bayer/gross-margin
14
Supporting Document 3: “Bayer Net Profit Margin 2006-2021: BAYRY.” Macrotrends,
www.macrotrends.net/stocks/charts/BAYRY/bayer/net-profit-margin
15
16
Supporting Document 4: Spross, Jeff. “Why Bayer Really Wants to Buy Monsanto.” The
monsanto
17
18
19
20
Supporting Document 5: Communications, Bayer AG. Bayer Plans Closing of Monsanto
closing-of-Monsanto-acquisition-on-June-7
21
22
23
Others
controversy/
24
25
26
Article 2: “Ansoff Matrix - Overview, Strategies and Practical Examples.” Corporate Finance
matrix/
27
28
29
30
31
Article 3: Bender, Ruth. “How Bayer-Monsanto Became One of the Worst Corporate Deals-in
12 Charts.” The Wall Street Journal, Dow Jones & Company, 28 Aug. 2019,
www.wsj.com/articles/how-bayer-monsanto-became-one-of-the-worst-corporate-dealsin-12-
charts-11567001577#refreshed
32
33
34
35
36
37
38
39
Article 4: Carlson, Rosemary. “What Is Gross Profit Margin?” The Balance Small Business,
40
41
42
Article 5: Dewey, Caitlin. “Why 'Monsanto' Is No More.” The Washington Post, WP
monsanto-is-no-more/
43
44
Article 6: Maverick, J.B. “The Difference Between Gross Profit Margin and Net Profit Margin.”
www.investopedia.com/ask/answers/021215/what-difference-between-gross-profit-margin-
and-net-profit-margin.asp
45
46
47
48
49
50
51
52
Article 7: Stam, Claire. “Bayer Nearing Monsanto Deal amid Stakeholders Concerns.”
food/news/bayer-nearing-monsanto-deal-amid-stakeholders-concerns/
53
54
55
Article 8: “The Effects of Mergers and Acquisition on Employees.” Business Class: Trends
www.americanexpress.com/en-ca/business/trends-and-insights/articles/the-effects-of-
mergers-and-acquisition-on-employees/
56
57
58
59
Links
controversy/
matrix/
www.macrotrends.net/stocks/charts/BAYRY/bayer/gross-margin
www.macrotrends.net/stocks/charts/BAYRY/bayer/net-profit-margin
Bender, Ruth. “How Bayer-Monsanto Became One of the Worst Corporate Deals-in
12 Charts.” The Wall Street Journal, Dow Jones & Company, 28 Aug. 2019,
www.wsj.com/articles/how-bayer-monsanto-became-one-of-the-worst-corporate-dealsin-12-
charts-11567001577#refreshed
60
Carlson, Rosemary. “What Is Gross Profit Margin?” The Balance Small Business, 23
acquisition-on-June-7
more/
Maverick, J.B. “The Difference Between Gross Profit Margin and Net Profit Margin.”
www.investopedia.com/ask/answers/021215/what-difference-between-gross-profit-margin-
and-net-profit-margin.asp
Spross, Jeff. “Why Bayer Really Wants to Buy Monsanto.” The Week, The Week, 24
food/news/bayer-nearing-monsanto-deal-amid-stakeholders-concerns/
“The Effects of Mergers and Acquisition on Employees.” Business Class: Trends and
61
www.americanexpress.com/en-ca/business/trends-and-insights/articles/the-effects-of-
mergers-and-acquisition-on-employees/
62